Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (404)	11/13/2000 5:13:25 PM
From: BulbaMan	Respond to of 1833

Rick: Given BMY's reported October sales of 47,500 KDUS shares, I agree it makes sense that they were sellers (and held the stock price back) after the PR on the restricted cash. You wonder why Cadus doesn't just use this cash to buy the 2 million shares still held by BMY – of course, it's possible Icahn wants to buy more shares for his personal account. On the positive side: it doesn't look like BMY will sell under $1 a share. As for keeping track of KDUS volume, we need to keep in mind that BB figures aren't too reliable and there's often double-counting of trades.

To: scaram(o)uche who wrote (404)	11/14/2000 1:25:11 PM
From: sam	Read Replies (1) \| Respond to of 1833

biz.yahoo.com

To: scaram(o)uche who wrote (404)	11/14/2000 10:03:56 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1833

As we've discussed, SC 13D/A filed today (BMY)...... Item 4. Purpose of Transaction. The Company acquired the Common Stock of the Issuer for the purpose of making an investment in the Issuer and not with the view to, or for resale in connection with, any distribution thereof. The Common Stock of the Issuer was initially acquired in connection with a research collaboration between the Company and the Issuer which expired in July 1999. The Company and the Issuer are parties to a letter agreement (the "Letter Agreement") concerning the Company's shares of the Common Stock. Such Letter Agreement is filed as an exhibit hereto and is incorporated herein by reference. The Letter Agreement includes certain notice requirements and transfer restrictions with respect to the Company's shares of the Common Stock. Subject to market conditions and the Letter Agreement, the Company may, in its sole discretion, sell all or a portion of its shares of Common Stock from time to time in open market transactions or otherwise. Item 5. Interest in Securities of the Issuer. To the best knowledge of the Company, the Company is the beneficial owner of 1,927,673 shares of Common Stock of the Issuer or approximately 14.6% of the Common Stock of the Issuer currently outstanding. The Company has the sole power to vote and dispose of all the shares of the Common Stock of the Issuer which it owns.